These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16251247)

  • 1. Strategies for improving long-term survival in patients with ESRD.
    Nolan CR
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S120-7. PubMed ID: 16251247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate binder therapy for attainment of K/DOQI bone metabolism guidelines.
    Nolan CR
    Kidney Int Suppl; 2005 Jul; (96):S7-14. PubMed ID: 15954948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
    West SL; Swan VJ; Jamal SA
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of hyperphosphatemia among patients with ESRD.
    Coladonato JA
    J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S107-14. PubMed ID: 16251245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing cardiovascular disease in patients with renal disease.
    Crook ED; Washington DO
    Ethn Dis; 2002; 12(4):S3-1-4. PubMed ID: 12477146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for improving long-term survival in peritoneal dialysis patients.
    Kendrick J; Teitelbaum I
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1123-31. PubMed ID: 20430945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
    Martola L; Elinder CG; Stenvinkel P
    Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate treatment of cardiovascular disease and cardiovascular disease risk factors in dialysis patients: a commentary.
    Culleton BF; Hemmelgarn B
    Semin Dial; 2004; 17(5):342-5. PubMed ID: 15461738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between blood pressure and mortality in ESRD-not different from the general population?
    Lacson E; Lazarus JM
    Semin Dial; 2007; 20(6):510-7. PubMed ID: 17991196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of pretransplant dialysis on outcomes in renal transplantation.
    Meier-Kriesche HU; Schold JD
    Semin Dial; 2005; 18(6):499-504. PubMed ID: 16398713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familiality of cardiovascular mortality in end-stage renal disease patients.
    Naiman N; Cheung AK; Goldfarb-Rumyantzev AS
    Am J Nephrol; 2009; 29(3):237-43. PubMed ID: 18799871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease: a risk factor for cardiovascular disease.
    Wali RK; Henrich WL
    Cardiol Clin; 2005 Aug; 23(3):343-62. PubMed ID: 16084283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant management of end-stage renal disease patients to minimize posttransplant risk.
    Jardine AG
    Transplantation; 2000 Dec; 70(11 Suppl):SS46-50. PubMed ID: 11152231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term patient survival: strategies to improve overall health.
    Adams PL
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S65-85. PubMed ID: 16567242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.